Crossmark

Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s12032-014-0435-4

Published Online: 2015-01-09

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Y. Q.

Yang, Y.

Zhuo, H. Y.

Zou, L. Q.

Jiang, Y.

Jiang, M.
License Information

Text and Data Mining valid from 2015-01-09

Document is current

Any future updates will be listed below